Long-term outcomes in Juvenile Myositis patients.
Seminars in Arthritis and Rheumatism
Funding: This work was supported in part by the Intramural Research program of the National Institute of Environmental Health Sciences [project ES101074 and ES1010081]. The work of Annette Aldous, Gulnara Mamyrova, Samuel Simmens, and Rodolfo V. Curiel was supported by the Cure JM Foundation. Annette Aldous and Samuel Simmens were also supported by the Clinical and Translational Science Institute at Children's National through the National Institutes of Health (NIH) Clinical and Translational Science Award (CTSA) program [grant UL1TR001876 and KL2TR001877]. The CTSA program is led by the NIH's National Center for Advancing Translational Sciences.
Tsaltskan, V., Aldous, A., Serafi, S., Yakovleva, A., Sami, H., Mamyrova, G., Targoff, I. N., Schiffenbauer, A., Miller, F. W., Simmens, S. J., Curiel, R., Jones, O. Y., & Rider, L. G. (2020). Long-term outcomes in Juvenile Myositis patients.. Seminars in Arthritis and Rheumatism, 50 (1). http://dx.doi.org/10.1016/j.semarthrit.2019.06.014